Advancing Manufacture of Cell and Gene Therapies VIII

More information coming soon.

San Diego

February 4-8, 2024
Loews Coronado Bay Hotel
Coronado, CA

Request for Next Mailing

About This Conference

The ECI Advancing Manufacture of Cell and Gene Therapies conference is a biennial meeting that brings together leading figures from academia, industry and government to showcase and debate the latest breakthroughs in advancing engineering and manufacturing of next generation therapies.

In February 2024, ECI will deliver yet another unique meeting with a specific focus on the latest advancements, trends and disruptions from the past two years impacting both cell and gene therapies. Our attendees and speakers include scientists and engineers in various sectors from all over the world working to improve manufacturing of advanced therapeutics. The sessions will cover advances and emerging concepts and technologies related to gene editing, digitalization and automation, manufacturing strategies, and much more. We welcome, celebrate, and take pride in achieving such a diverse environment that we feel helps deliver a very unique meeting. The conference delivers an appreciation of the field’s achievement, an acknowledgement of the hurdles, and a sense of direction for the future. Check back often as details on session titles, keynote speakers, and the overall program are updated regularly. We hope to see you there!

Conference Organization

Conference Chairs:

Fernanda Masri, Cell & Gene Catapult
Carolyn Yeago, Georgia Institute of Technology
Gargi Maheshwari, BMS
John Moscariello, BMS

Pre-Conference Workshop

Keynote Speakers

Call for Abstracts

Workshops

Call for Nominations and Cell and Gene Therapies Award

Advancing Manufacture of Cell and Gene Therapies Award

NOMINATION DEADLINE:  September 14, 2023

Purpose

The Advancing Manufacture of Cell and Gene Therapies Award recognizes outstanding contributors to the development and commercialization of Cell-Based Therapies. Past recipients include Bob Nerem, Kim Warren, Peter Zandstra and Greg Rusotti. 

The award nominations will be judged according to criteria as set forth in this document. 

Award

For each conference, an award of cash and a commemorative plaque will be presented to the recipient at the conference.  The 2024 award is sponsored by Engineering Conferences International (ECI).

Eligibility

This Award is open to all industrial and academic researchers and practitioners in the field of cell-based therapies. It is expected that the award recipient will register and attend the conference. 

Evaluation

Nomination packages will be evaluated by a committee of leaders in the field established by the conference chairs

Criteria

The nominations will be judged on the originality, impact, and overall quality of work; significance to the development and commercialization of cell-based therapies; and other supporting information in the nomination package. 

Nomination Package

(all documents should have 1 inch margins all around and use font no smaller than Arial 11 or Times 12 point). 

Self-nominations are welcome.  The nomination package must consist of the following items:

1) A nomination cover sheet;

2) A nomination letter of no more than 3 pages including a description of the nominee’s contributions to the development and commercialization of Cell-Based Therapies; and

3) A resume including publications, patents, and other contributions by the nominee.

Optional items:

A maximum of two supporting letters from individuals in the field may be provided. 

The items in the nomination package should include the following information:

1) Name of nominee

2) Present position (exact title)

3) Mailing address (including email)

4) Education, including (a) Institution; (b) Degree received; (c) Year; (d) Major or field 

5)  Positions held
a) Companies or institutions
b) Positions or titles
c) Time periods

6)  Academic and/or professional honors and awards

7)  Technical and professional society memberships and offices held

8)  Supporting letters

9)  Nominator’s name, address (including email), signature and date

THE COMPLETE NOMINATION PACKAGE should be submitted in electronic form as a SINGLE PDF FILE WITH THE NAME OF THE NOMINEE, and should include the scanned, signed letters of support (if any). 

Nomination packages are due by midnight EST September 14, 2023 to:

Barbara Hickernell, ECI Executive Director, at barbara@engconfintl.org

Call for Nominations for Chris Hewitt Award

Engineering Conferences International is pleased to announce that nominations for the Christopher Hewitt Outstanding Young Investigator Award are now open.  The award recipient will be a promising young scientist whose work shows exceptional promise in the field of process development of cell based and gene based therapies.  The award includes the opportunity to present their research at the conference as well as the waiver of the conference registration fee. 

Chris was a leading biological engineer, distinguished for his research using flow cytometry and cell sorting to understand the interaction of the cell with the bioreactor environment within such diverse areas as microbial fermentation, bio-remediation, bio-transformation, brewing and cell culture. He was also the co-founder of the Centre for Biological Engineering at Loughborough University, where he developed a world-leading team in regenerative medicine bioprocessing. In particular, his team made a significant contribution to the literature on the culture and recovery of fully functional human mesenchymal stem cells in stirred bioreactors based on sound biochemical engineering and fluid dynamic considerations essential to scale-up for commercialization.  In recognition of his achievements, he was elected Fellow of the Royal Academy of Engineering in 2018. 

Chris Hewett was an active contributor to the ECI conference series “Advancing Manufacturing for Cell based and Gene Based Therapies”.  

Eligibility:  Any graduate student or post-doc is eligible as is any researcher with fewer than 5 years of industrial or academic experience.  Individuals who meet these criteria are invited to submit an abstract to be considered for presentation at the 2024 Advancing Manufacture of Cell and Gene Therapies Conference, curriculum vitae; and two supporting letters of recommendation.  

Submission of Nominations: Nominations will be accepted from January 1, 2023 through September 15, 2023..  The abstract should be submitted through the normal ECI procedure but a copy of it should accompany the curriculum vita and letters of recommendation.  Please email to barbara@engconfintl.org – subject line should read: Christopher Hewitt Award Nomination for (name of nominee)

Sponsors

Sponsor Packages

Package A – Basic sponsorship: $3,300 

  • Name of Company on Sponsor List in program 

Package A+ – Basic social event sponsorship (limit 3 – first come first served): $5,000

  • Name of Company on Sponsor List in program 
  • Branding (banner) at evening social event (banner to be provided by sponsoring company) 

Package B – Sponsor a break: $6,500  

  • Name of Company on Sponsor List in program 
  • Named sponsor at an event (e.g., coffee break, poster session) 
  • Full page advertisement in digital program 
  • Company logo and link on conference website 
  • Company logo displayed on screen between sessions

Package C – Exhibit and attend: $13,500 

  • Name of Company on Sponsor List in program 
  • Full page advertisement in digital program 
  • Company logo and link on conference website 
  • Company logo displayed on screen between sessions 
  • Table display 
  • 1 complimentary all-inclusive registration 

Package D – Sponsor a session (first come first served): $23,500 

  • Name of Company on Sponsor List in program 
  • Full page advertisement in digital program 
  • Company logo and link on conference website 
  • Company logo displayed on screen between sessions 
  • Table display (premium location – sponsor’s choice) 
  • Sponsor a session: includes introduction to the session chairs and 1 slide (2 min) to introduce the  company 
  • 1 complimentary all-inclusive registration 
  • Digital advertisement pre-conference announcement / program 
  • Company information packet available in attendees’ registration materials 

Kevin Korpics (kevin@engconfintl.org) (+1-212-514-6760) may be contacted for invoicing and other  questions. Please make checks payable to:  

Engineering Conferences International 
Attn: Advancing Manufacturing of Cell & Gene Therapies VIII 
369 Lexington Ave., Suite 389 
New York, NY 10017 

Payment can also be made via wire transfer or credit card. Please note that a 3.5% transaction fee will be  applied to contributions made by credit card. You must reference your company name and the conference title “Advancing Manufacture of Cell & Gene  Therapies VIII” or code (24-AT) so the contribution can be identified. Thank you in advance.

Venue Information

The conference will take place at Loews Coronado Bay Hotel (4000 Coronado Bay Road, Coronado, California).  Set on Coronado Bay directly across the street from Silver Strand State Beach, the hotel is just over two miles to San Diego National Wildlife Refuge Complex. The hotel is set on a 15-acre peninsula with beach access via a pedestrian underpass.  The multi-building, three-floor resort offers 439 rooms and suite that are light and airy. Room views include bay, marina, pool or gardens. There is free Wi-Fi and the rooms have Keurig coffeemakers and ample outlets. The hotel has tennis courts, bicycle rentals, a fitness center, spa and three swimming pools.  Both self and valet parking are available for an additional fee.

San Diego attractions such as the San Diego Zoo, Balboa Park and the Gaslamp Quarter are each approximately a 25 minute trip from the hotel.

General Information About ECI

Engineering Conferences International (ECI) is a not-for-profit, global engineering conferences program, originally established in 1962 that provides opportunities for the exploration of problems and issues of concern to engineers and scientists from many disciplines.

The format of the conference provides morning and late afternoon or evening sessions in which major presentations are made. Poster sessions will be scheduled for evening discussion as well. Available time is included during the afternoons for ad hoc meetings, informal discussions, and/or recreation. This format is designed to enhance rapport among participants and promote dialogue on the development of the meeting. We believe the conferences have been instrumental in generating ideas and disseminating information to a greater extent than is possible through more conventional forums.

All participants are expected both to attend the entire conference and to contribute actively to the discussions. The recording/photographing of lectures and presentations is forbidden. As ECI conferences take place in an informal atmosphere, casual clothing is the usual attire.

Smoking is prohibited at ECI conferences and conference functions.